Page 82 - Eshre Final Programme 2015
P. 82
TUESDAY 16 JUNE 2015
08:30 - 09:30 Lisbon
Invited session: Session 26: Treating mitochondrial disease through assisted reproductive technologies - MHR session
Chairman: C. Barratt (United Kingdom) Chairman: A. Veiga (Spain)
08:30 O-095
Preventing the transmission of mitochondrial DNA disease
H.J.M. Smeets1, S.C.E.H. Sallevelt2, J.C.F.M. Dreesen3, C.E.M. De Die3, A.B.C. Otten3, D.M.E.I. Hellebrekers4, D.C. Samuels5, I.F.M. De Coo6
1Maastricht University Medical Center, Department of Clinical Genetics School for Growth and Development and for Cardiovascular Research, Maastricht, The Netherlands
2Maastricht University Medical Center, Department of Clinical Genetics School for Cardiovascular Research, Maastricht, The Netherlands
3Maastricht University Medical Center, Department of Clinical Genetics School for Growth and Development, Maastricht, The Netherlands
4Maastricht University Medical Center, Department of Clinical Genetics, Maastricht, The Netherlands
5Vanderbilt University Medical Center, Department of Molecular Physiology and Biophysics Center for Human Genetics Research, Nashville, U.S.A.
6Erasmus MC-Sophia Children’s Hospital, Department of Pediatric Neurology, Rotterdam, The Netherlands
Towards therapeutic application of IVF-based techniques to prevent transmission of mtDNA disease
L. Hyslop1, L. Irving1, J. Richardson1, L. Craven2, M. Choudhary3, A. Murdoch3, D. Turnbull2,
M. Herbert1
1Institute of Genetic Medicine, Wellcome Trust Centre for Mitochondrial Research, Newcastle Upon Tyne, United Kingdom
2Institute of Neuroscience, Wellcome Trust Centre for Mitochondrial Research, Newcastle Upon Tyne, United Kingdom
3Newcastle Fertility Centre at LIFE, Newcastle Upon Tyne, United Kingdom
09:00 O-096
82
